Cytotrait Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.62M

  • Investors
  • 7

Cytotrait General Information

Description

Developer of organelle-targeted gene editing technology designed to enable crop trait engineering and agricultural improvement. The company offers a proprietary approach that edits chloroplast and mitochondrial genomes to achieve homoplasmy with compartmentalized, high-level expression rapidly, reduces transgene phytotoxicity, simplifies backcrossing and trait stacking, strengthens genetic containment, and follows a clearer regulatory path with potential carbon savings, enabling seed companies, crop breeders, and agri-biotech firms to enhance yield, resilience, pest and disease resistance, and hybrid production efficiency.

Contact Information

Website
www.cytotrait.com
Formerly Known As
Plant Organelle Technologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O Umif Core Technology Facility
  • 46 Grafton Street
  • Manchester M13 9NT
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Vertical(s)
AgTech, Life Sciences
Corporate Office
  • C/O Umif Core Technology Facility
  • 46 Grafton Street
  • Manchester M13 9NT
  • England, United Kingdom

Cytotrait Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytotrait Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 09-Mar-2026 $4.62M Completed Startup
3. Grant 01-Sep-2025 Completed Startup
2. Accelerator/Incubator 01-Jan-2025 Completed Startup
1. University Spin-Out 24-Oct-2023 Completed Startup
To view Cytotrait’s complete valuation and funding history, request access »

Cytotrait Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
Seed
To view Cytotrait’s complete cap table history, request access »

Cytotrait Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Cytotrait Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024346662-A1 Methods of producing homoplasmic modified plants or parts thereof Pending 22-Sep-2023
EP-4780968-A1 Methods of producing homoplasmic modified plants or parts thereof Pending 22-Sep-2023
WO-2025062150-A8 Methods of producing homoplasmic modified plants or parts thereof Inactive 22-Sep-2023 C12N15/8214

Cytotrait Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytotrait Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Northern Gritstone Venture Capital Minority
Northern Universities Ventures Fund Venture Capital Minority
Parkwalk Advisors Venture Capital Minority
UK Innovation & Science Seed Fund Venture Capital Minority
Advanced Research + Invention Agency Government
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Cytotrait FAQs

  • When was Cytotrait founded?

    Cytotrait was founded in 2023.

  • Where is Cytotrait headquartered?

    Cytotrait is headquartered in Manchester, United Kingdom.

  • What is the size of Cytotrait?

    Cytotrait has 5 total employees.

  • What industry is Cytotrait in?

    Cytotrait’s primary industry is Biotechnology.

  • Is Cytotrait a private or public company?

    Cytotrait is a Private company.

  • What is the current valuation of Cytotrait?

    The current valuation of Cytotrait is .

  • What is Cytotrait’s current revenue?

    The current revenue for Cytotrait is .

  • How much funding has Cytotrait raised over time?

    Cytotrait has raised $4.62M.

  • Who are Cytotrait’s investors?

    Northern Gritstone, Northern Universities Ventures Fund, Parkwalk Advisors, UK Innovation & Science Seed Fund, and Advanced Research + Invention Agency are 5 of 7 investors who have invested in Cytotrait.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process